Skip to main content
CTOS 2023 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Paper 79 - IMPACT OF CENTER VOLUME ON INDIVIDUAL PROGNOSTICATION OF PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA: UPDATE OF SARCULATOR NOMOGRAMS

Saturday, November 4, 2023
2:00 PM – 3:00 PM  

    Author(s)

  • Dario Callegaro, MD

    Staff, Surgical Oncology
    Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Milan, Lombardia, Italy

    Slides

    • Co-Author(s)

  • FB

    Francesco Barretta, PhD

    Health Researcher
    Fondazione IRCCS IStituto Nazionale dei Tumori, Milan, Italy
    Milan, Lombardia, Italy

  • Chandrajit P. Raut, MD, MSc, FACS, FSSO (he/him/his)

    Surgical Oncologist
    Brigham and Women’s Hospital/Harvard Medical School
    Boston, Massachusetts, United States

  • WJ

    Wendy Johnston, PhD (she/her/hers)

    Sarcoma Clinical Research Manager
    Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada
    Toronto, Ontario, Canada

  • Dirk Strauss, MD

    Surgical Oncologist
    Royal Marsden NHS Foundation Trust
    London, England, United Kingdom

  • CH

    Charles Honorè, MD, PhD

    Institut Gustave Roussy, Villejuif, France
    Villejuif, Ile-de-France, France

  • Sylvie Bonvalot, MD, PhD

    Head, Sarcoma surgery
    Institut Curie
    Paris, Ile-de-France, France

  • Mark Fairweather, MD

    Surgical Oncologist
    Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston
    Boston, Massachusetts, United States

  • Piotr L. Rutkowski, MD, PhD

    Head of Department of Soft Tissue/Bone Sarcoma and Melanoma
    Maria Sklodowska-Curie National Research Institute of Oncology, Department of Soft Tissue/Bone Sarcoma and Melanoma, Warsaw Poland
    Warsaw, Mazowieckie, Poland

  • Winan J. van Houdt, MD, PhD, MS

    Surgical Oncology
    Netherlands Cancer Institute/ Antoni van Leeuwenhoek
    Amsterdam, Noord-Holland, Netherlands

  • Rebecca Gladdy, MD, PhD (she/her/hers)

    Surgical Oncologist Clinician-Scientist Associate Professor of Surgery
    Mount Sinai Hospital, Sinai Health System, and Princess Margaret Cancer Centre Toronto, ON, Canada Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, ON, Canada University of Toronto, Toronto, ON
    Toronto, Ontario, Canada

  • Fabio Tirotta, MD

    Sarcoma Surgical Oncologist
    Midlands Abdominal and Retroperitoneal Sarcoma Unit, University Hospital Birmingham NHS Foundation Trust
    Birmingham, England, United Kingdom

  • Dimitri Tzanis, MD, PhD (he/him/his)

    Consultant Surgical Oncologist
    Institut Curie
    Paris, Ile-de-France, France

  • JS

    Jacek Skoczylas, MD

    Maria Sklodowska-Curie National Research Institute of Oncology
    Warsaw, Mazowieckie, Poland

  • Rick Haas, MD, PhD (he/him/his)

    Senior staff member
    The Netherlands Cancer Institute
    Amsterdam, Drenthe, Netherlands

  • Rosalba Miceli, MD, PhD (she/her/hers)

    Director of Unit of Biostatistics for Clinical Research
    Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Milan, Lombardia, Italy

  • CS

    Carol Swallow, MD, PhD

    Mount Sinai Hospital, Toronto, ON, Canada
    Toronto, Ontario, Canada

  • Alessandro Gronchi, MD, FSSO (he/him/his)

    Chief Sarcoma Service and Chair of the Department of Surgery
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Milan, Lombardia, Italy